Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study
Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID...
Uložené v:
| Vydané v: | Nature communications Ročník 14; číslo 1; s. 5275 - 13 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
29.08.2023
Nature Publishing Group Nature Portfolio |
| Predmet: | |
| ISSN: | 2041-1723, 2041-1723 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16–1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20–3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39–2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47–4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.
The impacts of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy are not fully understood. Here, the authors perform a cohort study using data from Scotland and find that infection was associated with increased risk of preterm birth and some adverse maternal outcomes, but there was no evidence of adverse outcomes associated with vaccination. |
|---|---|
| AbstractList | Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16–1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20–3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39–2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47–4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.The impacts of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy are not fully understood. Here, the authors perform a cohort study using data from Scotland and find that infection was associated with increased risk of preterm birth and some adverse maternal outcomes, but there was no evidence of adverse outcomes associated with vaccination. Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection. Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection. Abstract Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16–1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20–3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39–2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47–4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection. Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16–1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20–3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39–2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47–4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection. The impacts of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy are not fully understood. Here, the authors perform a cohort study using data from Scotland and find that infection was associated with increased risk of preterm birth and some adverse maternal outcomes, but there was no evidence of adverse outcomes associated with vaccination. |
| ArticleNumber | 5275 |
| Author | McCowan, Colin Katikireddi, Srinivasa Vittal Carruthers, Jade Lindsay, Laura Hopcroft, Lisa E. M. Hopkins, Leanne Wood, Rachael Goulding, Anna McCabe, Ronan Calvert, Clara Shi, Ting Donaghy, Jack McLaughlin, Terry Taylor, Bob Stock, Sarah J. Bhaskaran, Krishnan Moore, Emily Robertson, Chris Denny, Cheryl Simpson, Colin R. Sheikh, Aziz |
| Author_xml | – sequence: 1 givenname: Laura orcidid: 0000-0002-0512-1640 surname: Lindsay fullname: Lindsay, Laura organization: Public Health Scotland – sequence: 2 givenname: Clara orcidid: 0000-0003-3272-1040 surname: Calvert fullname: Calvert, Clara organization: Usher Institute, University of Edinburgh, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine – sequence: 3 givenname: Ting orcidid: 0000-0002-4101-4535 surname: Shi fullname: Shi, Ting organization: Usher Institute, University of Edinburgh – sequence: 4 givenname: Jade surname: Carruthers fullname: Carruthers, Jade organization: Public Health Scotland – sequence: 5 givenname: Cheryl orcidid: 0000-0003-4616-4732 surname: Denny fullname: Denny, Cheryl organization: Public Health Scotland – sequence: 6 givenname: Jack surname: Donaghy fullname: Donaghy, Jack organization: Public Health Scotland – sequence: 7 givenname: Lisa E. M. orcidid: 0000-0002-7022-1322 surname: Hopcroft fullname: Hopcroft, Lisa E. M. organization: Public Health Scotland, National Services Scotland – sequence: 8 givenname: Leanne orcidid: 0000-0002-7487-4363 surname: Hopkins fullname: Hopkins, Leanne organization: Public Health Scotland – sequence: 9 givenname: Anna orcidid: 0000-0002-1288-3256 surname: Goulding fullname: Goulding, Anna organization: Public Health Scotland, Gloucestershire Hospitals NHS Foundation Trust – sequence: 10 givenname: Terry surname: McLaughlin fullname: McLaughlin, Terry organization: Public Health Scotland – sequence: 11 givenname: Emily orcidid: 0000-0002-9634-3299 surname: Moore fullname: Moore, Emily organization: Public Health Scotland – sequence: 12 givenname: Bob orcidid: 0000-0003-4314-2685 surname: Taylor fullname: Taylor, Bob organization: Public Health Scotland – sequence: 13 givenname: Krishnan orcidid: 0000-0001-5364-8757 surname: Bhaskaran fullname: Bhaskaran, Krishnan organization: Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine – sequence: 14 givenname: Srinivasa Vittal orcidid: 0000-0001-6593-9092 surname: Katikireddi fullname: Katikireddi, Srinivasa Vittal organization: Public Health Scotland, MRC/CSO Social & Public Health Sciences Unit, University of Glasgow – sequence: 15 givenname: Ronan surname: McCabe fullname: McCabe, Ronan organization: MRC/CSO Social & Public Health Sciences Unit, University of Glasgow – sequence: 16 givenname: Colin orcidid: 0000-0002-9466-833X surname: McCowan fullname: McCowan, Colin organization: School of Medicine, University of St Andrews – sequence: 17 givenname: Colin R. orcidid: 0000-0002-5194-8083 surname: Simpson fullname: Simpson, Colin R. organization: Usher Institute, University of Edinburgh, Wellington Faculty of Health, Victoria University of Wellington – sequence: 18 givenname: Chris orcidid: 0000-0001-6848-5241 surname: Robertson fullname: Robertson, Chris organization: Public Health Scotland, Department of Mathematics and Statistics, University of Strathclyde – sequence: 19 givenname: Aziz surname: Sheikh fullname: Sheikh, Aziz organization: Usher Institute, University of Edinburgh – sequence: 20 givenname: Rachael orcidid: 0000-0003-4453-623X surname: Wood fullname: Wood, Rachael email: Rachael.Wood@phs.scot organization: Public Health Scotland, Usher Institute, University of Edinburgh – sequence: 21 givenname: Sarah J. orcidid: 0000-0003-4308-856X surname: Stock fullname: Stock, Sarah J. organization: Public Health Scotland, Usher Institute, University of Edinburgh |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37644002$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1v1DAUjFARLUv_AAcUiQsXgz8Tmwuqlq-VKipR6NVyHHvXVdZebKeoJ_463qSUtof68vzsmfFY855XBz54U1UvEXyLIOHvEkW0aQHEBFAoGgbEk-oIQ4oAajE5uLM_rI5TuoRlEYE4pc-qQ9I2lEKIj6o_30zwKquhVr6vtyqb6EsTxqzD1qTahmEIv51f1-cn38_BMlwAXDtvjc4u-Im0PLtYfQRI1FdKa1fEysX7WtW7sBuHqQOdSmZS15tSddiEmOuUx_76RfXUqiGZ45u6qH5-_vRj-RWcnn1ZLU9OgWYUZYBIT7jSFKIOcQOFZbbjreWdxrSBtidEEI6toAzSnnbWth3qeshEb3tKKCKLajXr9kFdyl10WxWvZVBOTgchrqWK2enByKZhmLctNIwoapXp-o5SpoSGnArC9lofZq3d2G1Nr43PUQ33RO_feLeR63AlEaQNY8XqonpzoxDDr9GkLLcuaTMMypswJok544K3FPECff0AehnGfUYzipXscVNQr-5auvXyL-gCwDNAx5BSNPYWgqDcD5ScB0oWrJwGSu5t8gck7fKUaPmWGx6nkpmayjt-beJ_24-w_gJvqt6P |
| CitedBy_id | crossref_primary_10_1007_s10654_025_01268_z crossref_primary_10_1093_trstmh_trad093 crossref_primary_10_1016_S2352_4642_25_00008_2 crossref_primary_10_3390_vaccines12010057 crossref_primary_10_1097_GRF_0000000000000885 crossref_primary_10_1001_jama_2023_26945 crossref_primary_10_1172_JCI179230 crossref_primary_10_1016_j_cellimm_2024_104807 crossref_primary_10_1002_ijgo_15784 crossref_primary_10_1111_ppe_13105 crossref_primary_10_1186_s12884_024_06657_y crossref_primary_10_3310_FFSS9010 crossref_primary_10_7189_jogh_14_03046 crossref_primary_10_1016_j_cmi_2025_03_014 crossref_primary_10_1016_j_ijid_2025_108050 crossref_primary_10_1186_s12884_024_06816_1 crossref_primary_10_1155_cjid_6115890 crossref_primary_10_1016_j_placenta_2025_05_003 crossref_primary_10_1038_s41372_025_02237_w |
| Cites_doi | 10.1136/bmjopen-2020-042813 10.1038/s41591-021-01666-2 10.1001/jamapediatrics.2022.3456 10.1016/S0895-4356(96)00236-3 10.1136/bmj-2021-069741 10.1001/jamapediatrics.2022.0001 10.1016/S2213-2600(22)00360-5 10.1136/bmj-2022-071416 10.1136/bmj-2021-069739 10.1093/infdis/jiab626 10.1016/j.ajic.2022.08.014 10.1093/ije/dyab243 10.1038/s41467-022-35771-8 10.1186/s12884-022-04884-9 10.1002/bdr2.2081 10.1056/NEJMoa2104983 10.1016/j.ijsu.2014.07.013 10.1038/s41467-022-33937-y 10.1038/s41467-022-30052-w 10.1136/bmj.m3320 10.2139/ssrn.4322399 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. Springer Nature Limited. The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Springer Nature Limited 2023 |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. Springer Nature Limited. – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Springer Nature Limited 2023 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
| DOI | 10.1038/s41467-023-40965-9 |
| DatabaseName | Springer Nature OA Free Journals (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Coronavirus Research Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-1723 |
| EndPage | 13 |
| ExternalDocumentID | oai_doaj_org_article_66528770e53a4faebdb445a9c0849351 PMC10465539 37644002 10_1038_s41467_023_40965_9 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom--UK Scotland |
| GeographicLocations_xml | – name: United Kingdom--UK – name: Scotland |
| GrantInformation_xml | – fundername: NRS Senior Clinical Fellowship (SCAF/15/02) and Scottish Government Chief Scientist Office (SPHSU17). – fundername: UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK (MC_PC_19004) – fundername: Wellcome Trust (Wellcome) grantid: 209560/Z/17/Z funderid: https://doi.org/10.13039/100004440 – fundername: RCUK | Medical Research Council (MRC) grantid: MC_UU_00022/2; MC_PC_19075 funderid: https://doi.org/10.13039/501100000265 – fundername: Medical Research Council grantid: MC_UU_00022/2 – fundername: Medical Research Council grantid: MC_PC_19075 – fundername: Medical Research Council grantid: MC_PC_20058 – fundername: ; – fundername: ; grantid: MC_UU_00022/2; MC_PC_19075 – fundername: ; grantid: 209560/Z/17/Z |
| GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M48 M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX AFFHD CITATION PHGZM PHGZT PJZUB PPXIY PQGLB AARCD CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 5PM |
| ID | FETCH-LOGICAL-c541t-13d38ac401b18e09f5fb87f8bc2460fd339382f94504d4bff7b1bd059dfd43413 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 23 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001057947000020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2041-1723 |
| IngestDate | Tue Oct 14 18:48:45 EDT 2025 Tue Nov 04 02:06:17 EST 2025 Sun Nov 09 11:04:27 EST 2025 Tue Oct 07 07:07:12 EDT 2025 Sat Aug 02 01:41:22 EDT 2025 Sat Nov 29 03:29:23 EST 2025 Tue Nov 18 22:26:27 EST 2025 Fri Feb 21 02:39:53 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2023. Springer Nature Limited. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c541t-13d38ac401b18e09f5fb87f8bc2460fd339382f94504d4bff7b1bd059dfd43413 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4314-2685 0000-0002-7022-1322 0000-0003-4308-856X 0000-0002-0512-1640 0000-0002-4101-4535 0000-0002-9634-3299 0000-0003-3272-1040 0000-0001-6593-9092 0000-0002-9466-833X 0000-0001-5364-8757 0000-0002-5194-8083 0000-0003-4616-4732 0000-0003-4453-623X 0000-0002-7487-4363 0000-0001-6848-5241 0000-0002-1288-3256 |
| OpenAccessLink | https://www.proquest.com/docview/2858509626?pq-origsite=%requestingapplication% |
| PMID | 37644002 |
| PQID | 2858509626 |
| PQPubID | 546298 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_66528770e53a4faebdb445a9c0849351 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10465539 proquest_miscellaneous_2858987418 proquest_journals_2858509626 pubmed_primary_37644002 crossref_primary_10_1038_s41467_023_40965_9 crossref_citationtrail_10_1038_s41467_023_40965_9 springer_journals_10_1038_s41467_023_40965_9 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-08-29 |
| PublicationDateYYYYMMDD | 2023-08-29 |
| PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-29 day: 29 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature communications |
| PublicationTitleAbbrev | Nat Commun |
| PublicationTitleAlternate | Nat Commun |
| PublicationYear | 2023 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Calvert (CR7) 2022; 13 Allotey (CR2) 2020; 370 von Elm (CR26) 2014; 12 Watanabe (CR12) 2022; 176 Goldshtein (CR13) 2022; 176 CR35 Stock (CR16) 2020; 10 CR33 CR32 CR31 CR30 Nana (CR17) 2022; 377 Peduzzi, Concato, Kemper, Holford, Feinstein (CR34) 1996; 49 Neelam (CR19) 2022; 115 Fell (CR20) 2022; 378 Hagrass (CR9) 2022; 22 Badell, Dude, Rasmussen, Jamieson (CR6) 2022; 378 Prasad (CR21) 2022; 13 Stock (CR24) 2022; 10 CR4 CR3 Shimabukuro (CR11) 2021; 384 CR5 Stock (CR14) 2022; 28 CR29 CR28 CR27 CR25 CR23 Calvert (CR8) 2023; 14 CR22 Hameed (CR10) 2022; 51 Stock (CR15) 2022; 51 Pathirathna, Samarasekara, Dasanayake, Saravanakumar, Weerasekara (CR1) 2022; 10 Regan, Arah, Fell, Sullivan (CR18) 2022; 225 J Allotey (40965_CR2) 2020; 370 SJ Stock (40965_CR16) 2020; 10 A Watanabe (40965_CR12) 2022; 176 P Peduzzi (40965_CR34) 1996; 49 40965_CR35 40965_CR33 40965_CR31 I Hameed (40965_CR10) 2022; 51 40965_CR32 V Neelam (40965_CR19) 2022; 115 40965_CR30 C Calvert (40965_CR7) 2022; 13 ML Pathirathna (40965_CR1) 2022; 10 ML Badell (40965_CR6) 2022; 378 AK Regan (40965_CR18) 2022; 225 S Prasad (40965_CR21) 2022; 13 M Nana (40965_CR17) 2022; 377 DB Fell (40965_CR20) 2022; 378 40965_CR28 40965_CR29 40965_CR27 40965_CR25 40965_CR22 40965_CR23 C Calvert (40965_CR8) 2023; 14 SJ Stock (40965_CR24) 2022; 10 E von Elm (40965_CR26) 2014; 12 SJ Stock (40965_CR14) 2022; 28 TT Shimabukuro (40965_CR11) 2021; 384 AI Hagrass (40965_CR9) 2022; 22 I Goldshtein (40965_CR13) 2022; 176 40965_CR4 40965_CR5 SJ Stock (40965_CR15) 2022; 51 40965_CR3 |
| References_xml | – volume: 10 start-page: e042813 year: 2020 ident: CR16 article-title: COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data publication-title: BMJ Open doi: 10.1136/bmjopen-2020-042813 – ident: CR22 – volume: 28 start-page: 504 year: 2022 end-page: 512 ident: CR14 article-title: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland publication-title: Nat. Med doi: 10.1038/s41591-021-01666-2 – volume: 176 start-page: 1098 year: 2022 end-page: 1106 ident: CR12 article-title: Peripartum outcomes associated with COVID-19 vaccination during pregnancy: a systematic review and meta-analysis publication-title: JAMA Pediatr. doi: 10.1001/jamapediatrics.2022.3456 – ident: CR4 – ident: CR30 – ident: CR33 – volume: 49 start-page: 1373 year: 1996 end-page: 1379 ident: CR34 article-title: A simulation study of the number of events per variable in logistic regression analysis publication-title: J. Clin. Epidemiol. doi: 10.1016/S0895-4356(96)00236-3 – ident: CR35 – volume: 378 start-page: e069741 year: 2022 ident: CR6 article-title: Covid-19 vaccination in pregnancy publication-title: BMJ doi: 10.1136/bmj-2021-069741 – volume: 176 start-page: 470 year: 2022 end-page: 477 ident: CR13 article-title: Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early infant outcomes publication-title: JAMA Pediatr. doi: 10.1001/jamapediatrics.2022.0001 – volume: 10 start-page: 1129 year: 2022 end-page: 1136 ident: CR24 article-title: Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(22)00360-5 – ident: CR29 – volume: 378 start-page: e071416 year: 2022 ident: CR20 article-title: Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study publication-title: BMJ doi: 10.1136/bmj-2022-071416 – ident: CR25 – ident: CR27 – ident: CR23 – volume: 377 start-page: e069739 year: 2022 ident: CR17 article-title: Diagnosis and management of covid-19 in pregnancy publication-title: Bmj doi: 10.1136/bmj-2021-069739 – volume: 225 start-page: 759 year: 2022 end-page: 767 ident: CR18 article-title: SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a National US Cohort Study publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiab626 – volume: 51 start-page: 582 year: 2022 end-page: 593 ident: CR10 article-title: Is it safe and effective to administer COVID-19 vaccines during pregnancy? A systematic review and meta-analysis publication-title: Am. J. Infect. Control doi: 10.1016/j.ajic.2022.08.014 – volume: 51 start-page: e245 year: 2022 end-page: e255 ident: CR15 article-title: Cohort profile: the COVID-19 in Pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy publication-title: Int J. Epidemiol. doi: 10.1093/ije/dyab243 – ident: CR3 – volume: 14 year: 2023 ident: CR8 article-title: A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection publication-title: Nat. Commun. doi: 10.1038/s41467-022-35771-8 – volume: 10 start-page: 203 year: 2022 ident: CR1 article-title: Adverse perinatal outcomes in COVID-19 infected pregnant women: a systematic review and meta-analysis publication-title: Healthc. (Basel) – ident: CR31 – volume: 22 year: 2022 ident: CR9 article-title: Maternal and neonatal safety outcomes after SAR-CoV-2 vaccination during pregnancy: a systematic review and meta-analysis publication-title: BMC Pregnancy Childbirth doi: 10.1186/s12884-022-04884-9 – volume: 115 start-page: 145 year: 2022 end-page: 159 ident: CR19 article-title: Pregnancy and infant outcomes by trimester of SARS-CoV-2 infection in pregnancy-SET-NET, 22 jurisdictions, January 25, 2020-December 31, 2020 publication-title: Birth Defects Res. doi: 10.1002/bdr2.2081 – volume: 384 start-page: 2273 year: 2021 end-page: 2282 ident: CR11 article-title: Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2104983 – ident: CR32 – volume: 12 start-page: 1495 year: 2014 end-page: 1499 ident: CR26 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies publication-title: Int J. Surg. doi: 10.1016/j.ijsu.2014.07.013 – volume: 13 year: 2022 ident: CR7 article-title: A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection publication-title: Nat. Commun. doi: 10.1038/s41467-022-33937-y – ident: CR5 – volume: 13 year: 2022 ident: CR21 article-title: Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy publication-title: Nat. Commun. doi: 10.1038/s41467-022-30052-w – ident: CR28 – volume: 370 start-page: m3320 year: 2020 ident: CR2 article-title: Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.m3320 – ident: 40965_CR27 – volume: 28 start-page: 504 year: 2022 ident: 40965_CR14 publication-title: Nat. Med doi: 10.1038/s41591-021-01666-2 – ident: 40965_CR29 – volume: 384 start-page: 2273 year: 2021 ident: 40965_CR11 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2104983 – ident: 40965_CR25 – volume: 22 year: 2022 ident: 40965_CR9 publication-title: BMC Pregnancy Childbirth doi: 10.1186/s12884-022-04884-9 – ident: 40965_CR23 – volume: 225 start-page: 759 year: 2022 ident: 40965_CR18 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiab626 – volume: 10 start-page: 1129 year: 2022 ident: 40965_CR24 publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(22)00360-5 – volume: 49 start-page: 1373 year: 1996 ident: 40965_CR34 publication-title: J. Clin. Epidemiol. doi: 10.1016/S0895-4356(96)00236-3 – volume: 10 start-page: e042813 year: 2020 ident: 40965_CR16 publication-title: BMJ Open doi: 10.1136/bmjopen-2020-042813 – ident: 40965_CR4 – volume: 176 start-page: 1098 year: 2022 ident: 40965_CR12 publication-title: JAMA Pediatr. doi: 10.1001/jamapediatrics.2022.3456 – volume: 378 start-page: e071416 year: 2022 ident: 40965_CR20 publication-title: BMJ doi: 10.1136/bmj-2022-071416 – volume: 115 start-page: 145 year: 2022 ident: 40965_CR19 publication-title: Birth Defects Res. doi: 10.1002/bdr2.2081 – ident: 40965_CR30 – volume: 378 start-page: e069741 year: 2022 ident: 40965_CR6 publication-title: BMJ doi: 10.1136/bmj-2021-069741 – volume: 51 start-page: 582 year: 2022 ident: 40965_CR10 publication-title: Am. J. Infect. Control doi: 10.1016/j.ajic.2022.08.014 – ident: 40965_CR32 – volume: 14 year: 2023 ident: 40965_CR8 publication-title: Nat. Commun. doi: 10.1038/s41467-022-35771-8 – ident: 40965_CR28 – volume: 12 start-page: 1495 year: 2014 ident: 40965_CR26 publication-title: Int J. Surg. doi: 10.1016/j.ijsu.2014.07.013 – volume: 51 start-page: e245 year: 2022 ident: 40965_CR15 publication-title: Int J. Epidemiol. doi: 10.1093/ije/dyab243 – ident: 40965_CR22 – ident: 40965_CR3 – volume: 10 start-page: 203 year: 2022 ident: 40965_CR1 publication-title: Healthc. (Basel) – volume: 176 start-page: 470 year: 2022 ident: 40965_CR13 publication-title: JAMA Pediatr. doi: 10.1001/jamapediatrics.2022.0001 – ident: 40965_CR5 – volume: 370 start-page: m3320 year: 2020 ident: 40965_CR2 publication-title: BMJ doi: 10.1136/bmj.m3320 – ident: 40965_CR33 – volume: 377 start-page: e069739 year: 2022 ident: 40965_CR17 publication-title: Bmj doi: 10.1136/bmj-2021-069739 – ident: 40965_CR35 doi: 10.2139/ssrn.4322399 – volume: 13 year: 2022 ident: 40965_CR21 publication-title: Nat. Commun. doi: 10.1038/s41467-022-30052-w – volume: 13 year: 2022 ident: 40965_CR7 publication-title: Nat. Commun. doi: 10.1038/s41467-022-33937-y – ident: 40965_CR31 |
| SSID | ssj0000391844 |
| Score | 2.5428638 |
| Snippet | Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here... Abstract Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5275 |
| SubjectTerms | 631/326/590 631/326/596/4130 692/308/174 692/699/255 Adult Apgar score Birth Childbirth & labor Cohort analysis Cohort Studies Confidence intervals COVID-19 COVID-19 - pathology COVID-19 vaccines COVID-19 Vaccines - adverse effects Critical care Death Decision making Female Gestational age Humanities and Social Sciences Humans Immunization Infant, Newborn Infections Mortality multidisciplinary Neonates Population studies Population-based studies Pregnancy Pregnancy Complications, Infectious - pathology Pregnancy Outcome Premature birth Risk Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Small for gestational age Statistical analysis Thromboembolism Vaccination |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQBRIXxJtAQUbiBlaT2I5tbmWhgsuCKFS9WX6KlVBS7aOIE3-dsZ0NXZ4XLjnEjzgz45mxx_4GoScmdMlNdYQ1Ah4hBQmVccR4Hhn3XBgWc7IJMZ_L01P17kKqr3QmrMADF8IddB0Hp17UgVNoZoL1ljFulKslUzRfnm7B67mwmMo6mCpYurDxlkxN5cGKZZ0AJgqWTKrjRO1YogzY_zsv89fDkj9FTLMhOrqOro0eJD4sI7-BLoX-JrpSckp-vYW-zUPaEIcapvcY_NEM8oyHzRpkK6xwBMYPX6BnfHz4_pjMhhPS4u2RrD43mr09efOSNAqfG-cWZbvwOTb4bEr2RZLxy70Dzz1OWXaXa5yham-jj0evPsxekzHLAnGcNSkXvafSOFhn2UaGWkUerRRRWteyro6eUkVlGxXjNfPMxihsYz14ZT56lmzgHbTXD324h7BwwjIro_DgGMguGCUTRJXraumctLRCzZbi2o0Q5CkTxmedQ-FU6sIlDVzSmUtaVejp1OasAHD8tfaLxMipZgLPzi9ApPQoUvpfIlWh_a0Y6HFGr3SbAqjwkbar0OOpGOZiCrCYPgybUkfJhAdUobtFaqaRgCJnoC_bCskdedoZ6m5Jv_iU8b5TGJ5zCj_3bCt6P8b1Z1rc_x-0eICutmnO1Omuzj7aWy834SG67M7Xi9XyUZ503wGHai1o priority: 102 providerName: Directory of Open Access Journals |
| Title | Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study |
| URI | https://link.springer.com/article/10.1038/s41467-023-40965-9 https://www.ncbi.nlm.nih.gov/pubmed/37644002 https://www.proquest.com/docview/2858509626 https://www.proquest.com/docview/2858987418 https://pubmed.ncbi.nlm.nih.gov/PMC10465539 https://doaj.org/article/66528770e53a4faebdb445a9c0849351 |
| Volume | 14 |
| WOSCitedRecordID | wos001057947000020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: P5Z dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (New) customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoCxIX3o9AWRmJG0RNYjuxuaB2aUUPLFEL1cIl8hNWQsmyjyJO_HU8zqNaHr1w8WHt7No745nxjPN9CD2TNocwVcc0LXxjoUgopI6lYY4ywwpJXSCbKCYTPp2Ksku4Lbtrlb1NDIbaNBpy5HsZFLB8vJ3lr-bfYmCNgupqR6GxhXYAJYGEq3vlkGMB9HNOafeuTEL43pIGy-AdlT84iZzFYsMfBdj-v8Waf16Z_K1uGtzR0c3_XcgtdKMLRPF-qzm30RVb30HXWmrKH3fRz4mFvLofIWuDfVgbsKJxs175X7FL7Lz-NN_91PDp_slpPG7O4gz3N7vq8ND43dnx6zgV-FxqPWuzji-xxPOBMywGHxq-3auOwUDWu1jhgHh7D304Onw_fhN3ZA2xZjQFSntDuNT-uKZSbhPhmFO8cFzpjOaJM4QIwjMnKEuoocq5QqXK-ODOOEPBld5H23VT24cIF7pQVHFXGB9f8NxKwQHpSucJ15orEqG0F1mlOyRzINT4WoWKOuFVK-bKi7kKYq5EhJ4Pz8xbHI9LRx-AJgwjAYM7fNAsPlfdlq7ynPnjZpFYRrxCS6uMopRJoRNOBWFphHZ7Bag6w7CsLqQfoadDt9_SUKeRtW3W7RjBAVYoQg9atRtm4v0B9WY3ixDfUMiNqW721LMvATYcqvmMEb-4F73uXszr3__Fo8uX8Rhdz2A7JfAyzy7aXi3W9gm6qs9Xs-VihLaKaRFaPkI7B4eT8mQU0h6jsFN9W7JPvqc8flt-_AUpVUNK |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKAcGFfQkUMBKcIGoWO7GRECpTqlYtQ0VL1ZvxCiOhZJilVU_8I34jz85SDUtvPXDJIXEi23nLZ7_n9yH0TNrCw1Qdk7SEi_VBQi51LA11hBpaSuIC2UQ5HLLDQ767hH52Z2F8WmVnE4OhNrX2e-SrmQ9gAd7Oijfj77FnjfLR1Y5CoxGLbXtyDEu26eutdfi_z7Ns493-YDNuWQViTUnquddNzqSGdYVKmU24o06x0jGlM1IkzuQ5z1nmOKEJMUQ5V6pUGUAhxhnibT589wK6CDAiYyFVcLff0_HV1hkh7dmcJGerUxIsEThGWKjxgsZ8wf8FmoC_Yds_UzR_i9MG97dx_X-buBvoWgu08VqjGTfRkq1uocsN9ebJbfRjaH3cAFrIymCA7aEWNq7nMxiVnWIH-lEfw1TgvbWPe_GgPogz3GWuVeGlwYeDrfU45fhIaj1qdlVfYYnHPSda7DFC-DqohsGejHgyw6Gi7x306VxGfxctV3Vl7yNc6lIRxVxpAD-xwkrOfCUvXSRMa6byCKWdiAjdVmr3hCHfRMgYyJloxEqAWIkgVoJH6EX_zripU3Jm67de8vqWvsZ4uFFPvojWZImioLCcLhNLc1BYaZVRhFDJdcIIz2kaoZVO4ERr-KbiVNoi9LR_DCbLx6FkZet504YzXzYpQvcaMe97Av6OgFvJIsQWFGChq4tPqtHXUBbdZytQmsPgXna6ctqvf8_Fg7OH8QRd2dx_vyN2tobbD9HVzKty4g8uraDl2WRuH6FL-mg2mk4eB1uA0efz1qFfK5mY1w |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKWcSFfRkoYCQ4QTRZ7MRGQqjMUDEqGkYUqt6C4wVGQskwS6ue-F_8Ot5zlmpYeuuBSw6JE9nO2-z3_H2EPFE2xTBVByzK4GIxSSiVDpThjnHDM8WcJ5vIxmNxcCAnG-RnexYGyypbm-gNtak07pH3Y0xgQbwdp33XlEVMhjuvZt8DZJDCTGtLp1GLyK49PoLl2-LlaAj_-mkc77z5OHgbNAwDgeYsQh52kwilYY1RRMKG0nFXiMyJQscsDZ1JEpmI2EnGQ2ZY4VxWRIWBiMQ4w9D-w3fPkfMZgpb7ssFJt7-DyOuCseacTpiI_oJ5qwROEhZtMuWBXPOFnjLgb3Hun-Wav-VsvSvcufo_T-I1cqUJwOl2rTHXyYYtb5CLNSXn8U3yY2wxnwAtVGkohPMeI5tWqyWM0C6oA72pjmBa6N72h71gUO0HMW0r2kr_0uD9_mgYRJIeKq2n9W7rC6rorONKCzB28F8HlTEUSYrnS-qRfm-RT2cy-ttks6xKe5fQTGcFK4TLDMRVIrVKCkT40mkotBZF0iNRKy65bhDckUjkW-4rCRKR1yKWg4jlXsRy2SPPundmNX7Jqa1foxR2LRF73N-o5l_yxpTlacphmZ2FliegyMoWpmCMK6lDwWTCox7ZaoUvbwziIj-RvB553D0GU4b5KVXaalW3kQLhlHrkTi3yXU_ADzJwN3GPiDVlWOvq-pNy-tXDpWMVA-cJDO55qzcn_fr3XNw7fRiPyCVQnfzdaLx7n1yOUatDPM-0RTaX85V9QC7ow-V0MX_ozQIln89ahX4Bku2hlA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neonatal+and+maternal+outcomes+following+SARS-CoV-2+infection+and+COVID-19+vaccination%3A+a+population-based+matched+cohort+study&rft.jtitle=Nature+communications&rft.au=Lindsay%2C+Laura&rft.au=Calvert%2C+Clara&rft.au=Shi%2C+Ting&rft.au=Carruthers%2C+Jade&rft.date=2023-08-29&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=5275&rft_id=info:doi/10.1038%2Fs41467-023-40965-9&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |